The impact of healthcare-associated methicillin-resistant Staphylococcus aureus infections on post-discharge costs and utilization

ID: AllID: Antibiotic-resistant bacteriaID: Healthcare-associated Infections (HAI)

Oct 9

Written By Sarah Rebbert

Sarah Rebbert

The economic value of identifying and treating Chagas disease patients earlier and the impact on Trypanosoma cruzi transmission

Dual-chamber injection device for measles-rubella vaccine: The potential impact of introducing varying sizes of the devices in 3 countries